Breaking News

Charles River Launches RightSource Service

By Kristin Brooks | February 20, 2014

Allows companies to outsource biologic QC testing

Charles River Laboratories has launched its new insourcing/outsourcing option to biotech and pharma companies, allowing them to completely externalize their quality control (QC) testing program to Charles River. After Charles River and the client identify the best combination of insourcing and outsourcing options, Charles River will be able to completely manage the client’s QC testing program, evaluate and select outsourcing vendors where necessary, and provide a dedicated project manager familiar with the technical aspects of the program to oversee all of client’s QC activities. 
 
“Growing demand for services such as RightSource points to the continued challenges biopharmaceutical companies face, as well as the increased reliance on drug development partners like Charles River, particularly in the area of biologics,” saidBirgit Girshick, corporate senior vice president, Research Models and Global Biopharmaceutical Services, Charles River.

Related Contract Manufacturing:

Related Compliance:

  • Analytical Testing Outsourcing Trends Update

    Analytical Testing Outsourcing Trends Update

    January 26, 2017
    Spurred by many factors, global analytical testing services market is experiencing rapid growth in the range of 11% per year

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus